Cas No 1260141-27-2 Manufacturers In India

By Author: Shobha
Total Articles: 3
Comment this article

Exploring the Landscape of CAS No. 1260141-27-2 Manufacturers in India
India's chemical industry stands as a formidable pillar of its industrial sector, contributing significantly to the nation's economic growth. Among the myriad of chemicals produced, CAS No. 1260141-27-2, known as Vonoprazan Fumarate, has garnered attention due to its role in pharmaceutical applications. This article delves into the landscape of Vonoprazan Fumarate manufacturers in India, highlighting the industry's capabilities, regulatory frameworks, and the broader implications for global supply chains.

Understanding Vonoprazan Fumarate (CAS No. 1260141-27-2)
Vonoprazan Fumarate is a potassium-competitive acid blocker (P-CAB) that has emerged as a significant advancement in the treatment of acid-related gastrointestinal disorders. Its efficacy in providing rapid and sustained acid suppression has made it a preferred choice over traditional proton pump inhibitors (PPIs). The chemical structure and properties of Vonoprazan Fumarate necessitate precise manufacturing processes, making its production a specialized endeavor.
India's Role ...
... in the Global Pharmaceutical Supply Chain
India has established itself as a global hub for pharmaceutical manufacturing, often referred to as the "pharmacy of the world." The country's robust infrastructure, skilled workforce, and adherence to international quality standards have enabled it to meet the growing global demand for active pharmaceutical ingredients (APIs) and finished dosage forms. The production of specialized compounds like Vonoprazan Fumarate underscores India's capability in handling complex chemical syntheses.
Regulatory Landscape Governing Pharmaceutical Manufacturing
The production of pharmaceutical-grade chemicals in India is governed by stringent regulatory frameworks to ensure safety, efficacy, and quality. Key regulatory bodies include:
Central Drugs Standard Control Organization (CDSCO): The national regulatory authority responsible for the approval of new drugs and monitoring the quality of pharmaceuticals.

State Drug Standard Control Organizations: These bodies oversee the manufacturing and sale of drugs within individual states, ensuring compliance with national standards.

Good Manufacturing Practices (GMP): Compliance with GMP is mandatory for pharmaceutical manufacturers, ensuring that products are consistently produced and controlled according to quality standards.

ISO Certifications: Many manufacturers obtain ISO certifications to demonstrate their commitment to quality management systems.

These regulatory measures ensure that manufacturers adhere to international standards, facilitating the production of high-quality pharmaceutical products.
Key Manufacturing Hubs in India
India's pharmaceutical manufacturing is concentrated in several regions, each known for its specialized capabilities:
Hyderabad, Telangana: Often dubbed the "Bulk Drug Capital of India," Hyderabad is home to numerous API manufacturers specializing in complex chemical syntheses.

Vapi and Ankleshwar, Gujarat: These industrial hubs are known for their large-scale chemical manufacturing units, producing a wide range of chemicals, including intermediates and APIs.

Mumbai, Maharashtra: As a major metropolitan city, Mumbai hosts several pharmaceutical companies engaged in both manufacturing and research activities.

Bengaluru, Karnataka: Known for its research and development prowess, Bengaluru also hosts manufacturing units focusing on high-value pharmaceutical products.

These regions benefit from established infrastructure, skilled labor, and proximity to key markets, making them attractive locations for pharmaceutical manufacturing.
Challenges in Manufacturing Specialized Compounds
The production of specialized compounds like Vonoprazan Fumarate presents unique challenges:
Complex Synthesis Routes: The chemical synthesis of Vonoprazan Fumarate involves multiple steps, each requiring precise control to ensure purity and yield.

Regulatory Compliance: Adhering to international regulatory standards necessitates rigorous documentation, quality control, and validation processes.

Supply Chain Management: Procuring raw materials of consistent quality and managing logistics for timely delivery are critical for maintaining production schedules.

Cost Management: The specialized nature of the compound can lead to higher production costs, necessitating efficient manufacturing processes to maintain profitability.

Despite these challenges, Indian manufacturers have demonstrated resilience and innovation, leveraging their expertise to meet global demands.
The Future Outlook
The global demand for specialized pharmaceutical compounds is expected to rise, driven by an aging population and increasing prevalence of chronic diseases. India's pharmaceutical industry is well-positioned to capitalize on this trend, owing to its established manufacturing capabilities and adherence to international standards.
Key factors influencing the future outlook include:
Investment in Research and Development: Ongoing R&D efforts are crucial for developing new and improved pharmaceutical compounds, ensuring competitiveness in the global market.

Adoption of Advanced Manufacturing Technologies: Implementing technologies like continuous manufacturing and automation can enhance efficiency and reduce production costs.

Strengthening Regulatory Compliance: Maintaining compliance with evolving international regulatory standards is essential for accessing global markets.

Sustainable Practices: Emphasizing environmental sustainability in manufacturing processes can enhance brand reputation and meet global environmental standards.

Conclusion
The production of Vonoprazan Fumarate in India exemplifies the country's capabilities in manufacturing specialized pharmaceutical compounds. Through adherence to stringent regulatory standards, investment in advanced manufacturing technologies, and a commitment to quality, Indian manufacturers continue to play a pivotal role in the global pharmaceutical supply chain. As the industry evolves, India's position as a leader in pharmaceutical manufacturing is poised to strengthen, contributing to global health outcomes and economic growth.
URL: For more information, visit Shobha Lifescience : CAS No. 1260141-27-2 Manufacturers in India